Fine Foods & Pharmaceuticals N.T.M. S.p.A.

BIT-FF
Borsa Italiana
Consumer Staples Packaged Foods
Global Rank
#19594
Country Rank
#135
Market Cap
227.53 M
Price
9.27
Change (%)
0.25%
Volume
1,722

Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s latest marketcap:

227.53 M

As of 07/28/2025, Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s market capitalization has reached $227.53 M. According to our data, Fine Foods & Pharmaceuticals N.T.M. S.p.A. is the 19594th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 227.53 M
Revenue (ttm) 281.59 M
Net Income (ttm) 10.92 M
Shares Out 24.48 M
EPS (ttm) 0.45
Forward PE 15.50
Ex-Dividend Date 04/28/2025
Earnings Date 09/11/2025
Market Cap Chart
Data Updated: 07/28/2025

Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s yearly market capitalization.

Fine Foods & Pharmaceuticals N.T.M. S.p.A. has seen its market value grow from €162.24 M to €195.37 M since 2018, representing a total increase of 20.42% and an annual compound growth rate (CAGR) of 2.86%.
Date Market Cap(€) Market Cap(USD) Change (%) Global Rank
07/28/2025 €195.37 M $227.53 M 5.33% 19594
12/30/2024 €183.62 M $190.09 M -14.53% 19289
12/29/2023 €214.83 M $237.11 M 4.97% 17815
12/30/2022 €204.65 M $219.02 M -45.35% 17494
12/30/2021 €374.46 M $425.6 M 57.45% 14362
12/30/2020 €237.83 M $290.48 M -12.66% 14741
12/30/2019 €272.31 M $305.34 M 67.84% 12661
12/28/2018 €162.24 M $186.03 M 14275

Company Profile

About Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Fine Foods & Pharmaceuticals N.T.M. S.p.A. specializes in contract development and manufacturing for the pharmaceutical and nutraceutical industries. The company produces a wide range of drugs, food supplements, nutraceutical products, and medical devices.

Key Offerings

  • Pharmaceutical Products: Powders, soluble granules, effervescent tablets, chewable tablets, fast-melting/sublingual tablets, film-coated tablets, and hard gelatine capsules.
  • Packaging Solutions: Sachets, sticks, pillboxes, jars, blisters, tubes, and strips.
  • Therapeutic Areas: Probiotics, multivitamins, immune support, sleep & relaxation, gastrointestinal health, circulatory health, osteoarticular care, urinary health, women's health, beauty, healthy ageing, and mental wellbeing.

Cosmetics & Personal Care

The company also engages in the research, development, and marketing of cosmetics, including:

  • Hair care, skin care, bath & shower products, shampoos, conditioners, and shaping waxes.
  • Oral hygiene products like mouthwash, toothpaste, and breath fresheners.
  • Deodorants (roll-on, stick, vapo spray), intimate cleansers, and alcohol-based perfumery products.
  • Packaging: Coextruded tubes, aluminium tubes, lip sticks, airless containers, bottles, and jars.

Global Presence

Operating in Italy, Germany, France, the UK, Spain, Greece, and internationally, Fine Foods & Pharmaceuticals N.T.M. S.p.A. serves both its own brands and third-party clients.

Founded: 1984 | Headquarters: Verdellino, Italy

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.